Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7754 USD | +3.19% | -5.02% | +14.06% |
May. 13 | AlloVir, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Evolution of the average Target Price on AlloVir, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering AlloVir, Inc.
Morgan Stanley | |
Leerink Partners | |
JPMorgan Chase | |
Piper Sandler | |
BofA Securities | |
SVB Securities LLC | |
SVB Leerink | |
BMO Capital |
EPS Revisions
- Stock Market
- Equities
- ALVR Stock
- Consensus AlloVir, Inc.